New study achieves 99 percent remission in children who relapse with most common childhood cancer

A recent collaboration with colleagues in Shanghai Children’s Medical Center has found a new immunotherapy combination that resulted in remission for virtually all children – 99 percent – who had relapsed B-cell acute lymphoblastic leukemia (ALL).

Read more: https://www.stjude.org/inspire/news/new-study-achieves-99-percent-remission-in-children-who-relapse-with-most-common-childhood-cancer.html